FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/24/2026
Back to search
Official data from USPTO
PADAGIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079421222Class
3, 5, 35, 42, 44
Filing
79421222
Registration
8182267
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/24/2026
Trademark type
Combined
Nice classes
3, 5, 35, 42, 44
Filing date
12/19/2024
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
06/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
US
Examiner
POLLACK, ALISON FRIEDBERG
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "Padagis". The letter "P" contains a design element in the upper left corner, consisting of a small square forming part of the letter structure. The remainder of the letters "adagis" appear in bold rounded lowercase font.
Holders and representatives
Holders
PADAGIS US LLC
Representatives
Andrea M. Porterfield Polsinelli PC
Technical classification
Nice Classes
Class 3Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cleaning preparations; hair lotions; shampoos; dentifrices; cosmetic creams; cosmetic preparations for face and body skin care; Non-medicated sun care preparations; cosmetic preparations for personal hygiene; cosmetic preparations for intimate care; non-medicated skin care preparationscreamslotionsgelstonerscleaners and peels for the treatment of hemorrhoidsfissureskin rasheseczemafungal infectionsitching; non-medicated skin care preparations for the treatment of hemorrhoidsfissureskin rasheseczemafungal infectionsitching
Class 5
Pharmaceutical preparations for the treatment of dermatologicalophthalmicrespiratorybacterial-basedurologicalhormonalgastrointestinalcardiovascularpsychiatric diseases and disorders; pharmaceutical preparations for the treatment of diabetesmigrainesseizures; pharmaceutical preparations for use in pain management; transdermal patches for use in the treatment of nausea and vomiting; transdermal patches for the delivery of hormonal preparations; pharmaceutical preparations for inhalation for use in treatment of respiratory diseases and disorders and chronic obstructive pulmonary disease (COPD); inhalers sold filled with aerosol inhalation productsantihistaminesdecongestants for medical use; nasal and oral spray preparations for use as central nervous system stimulants; anti-infective preparationspharmaceutical preparations for the treatment of infectious diseases; antiviral preparationspharmaceutical preparations for the treatment of viral infections; antibiotics; antifungal preparations; anti-inflammatory preparations; cough treatment preparations; topical pharmaceutical and medical preparations for the treatment of vaginal infections; anti-fungal preparations for diaper rashfor antibiotic usefor the treatment of alopecia; medical gelscreams and lubricants for dermatological use; disposable test strips for measuring blood glucose levels; suppositories being pharmaceutical preparations for hemorrhoidsfever and pain management; oral analgesics; topical analgesics; antacids; antihistamines; cough syrups; cough-expectorants; cough drops; decongestant preparations in the nature of decongestants in the form of tabletscapsulesnasal sprays and medicated oral care solutions and sprays; eye drops; dietary food supplements; laxatives; natural sleeping aid preparations; topical antibiotic creams and ointments; topical pharmaceutical preparations for the treatment of alopecia; pre-moistened medicated wipes; medicated eye pads for medical use; hormonal replacement therapy preparations; hormonal preparations; topical pharmaceutical preparations for hypogonadism; dermal and transdermal pharmaceutical preparations for dermatitis; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; antiparasitic preparations for veterinary purposes; pharmaceutical preparations for the treatment of acne and other skin disorders; pharmaceutical preparations for the treatment of infantile hemangioma; medicated pharmaceutical preparations for the treatment of hemorrhoidsfissureskin rasheseczemafungal infectionsitching; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology and haemato-oncology; pre-filled medical first aid kits and first aid prefilled injection syringes sold filled with pharmaceutical preparations for the treatment of drug overdosecardiovascularrespiratoryseizuregastrointestinalinfectionepilepsyhypogonadismitchingcoldfluallergydecongestant diseases and disordersantihistaminesas well as for pain relief and for the treatment of migraines; pharmaceutical preparationsantidepressants; pro-biotic medical preparationsprobiotic preparations for medical use; bowel cleansing preparations being bowel evacuant preparations; medicated lozenges and oral cavity throat sprays; pharmaceutical preparations for the treatment of cold sores; pharmaceutical preparations for the treatment of sleeping disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of flu; pharmaceutical preparations for the treatment of allergy; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; medicated smoking cessation preparations in the nature of gumslozenges and oral sprays; pharmaceuticals for treating vaginal infectionsvaginal antifungals and vaginal suppositories for the prevention and treatment of infections; lubricants for personal use; hygienic preparations for medical usenamely medicated bath preparations for intimate hygiene; vitamin preparations; mineral food-supplements; food supplements for medical use; mineral preparations for medical use; medicinal drinks; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for skin care; pharmaceutical and medicinal preparations for smoking cessation; probiotic supplements
Class 35
Business management services in relation to wholesale and retail of pharmaceuticalcosmetichygiene and beauty products for human usefood supplements and medical apparatus and instruments; demonstration of goods for promotional purposes; distribution of samples; import-export agency services; providing commercial information; sales promotion; promotional and advertising services; public relations; retail store services featuring medical pharmaceutical preparations
Class 42
Technical consultancy services in the field of pharmaceutical studies in relation to point-of-care products; product development consultancy services and providing product development services in the nature of technological updates in relation to self-testing products and point of care products; research and development in the fields of pharmaceuticals and medicine; research and development of new products for others; research and development of pharmaceutical preparations; design of pharmaceutical preparations; testing of pharmaceutical preparations
Class 44
Providing medical consultancy services in relation to self-testing and point-of-care products; medical services; veterinary services; hygienic and beauty care for human beings or animals
Publications
History of USPTO decisions and trademark events.
35 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/24/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2026
PUBO
PUBLISHED FOR OPPOSITION
02/03/2026
GPNX
NOTIFICATION PROCESSED BY IB
01/29/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/28/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/14/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/13/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
01/06/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/06/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
01/06/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/06/2026
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
01/06/2026
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
01/06/2026
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
01/06/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/05/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/03/2025
GNFR
FINAL REFUSAL E-MAILED
10/03/2025
CNFR
FINAL REFUSAL WRITTEN
10/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2025
RFNT
REFUSAL PROCESSED BY IB
08/02/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2025
RFRR
REFUSAL PROCESSED BY MPU
07/11/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/15/2025
CNRT
NON-FINAL ACTION WRITTEN
05/14/2025
DOCK
ASSIGNED TO EXAMINER
05/13/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/11/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/10/2025
Continuous trademark protection
Get notified about every new filing that threatens PADAGIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.